HLB Pharmaceutical Co (XKRX:047920) Ending Cash Position : ₩11,547 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Ending Cash Position?

HLB Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩11,547 Mil.

HLB Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (₩3,235 Mil) to Dec. 2023 (₩4,766 Mil) and increased from Dec. 2023 (₩4,766 Mil) to Mar. 2024 (₩11,547 Mil).

HLB Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2021 (₩6,640 Mil) to Dec. 2022 (₩9,744 Mil) but then declined from Dec. 2022 (₩9,744 Mil) to Dec. 2023 (₩4,766 Mil).

HLB Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for HLB Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Ending Cash Position Chart

HLB Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,743.84

14,083.32

6,639.60

9,744.38

4,766.32

HLB Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															7,147.90	5,549.25	3,235.02	4,766.32	11,546.73

HLB Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

HLB Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9744.376	+	-4978.058
	=	4,766

HLB Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4766.318	+	6780.413
	=	11,547

HLB Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Pharmaceutical Co (XKRX:047920) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR

Website

http://www.hlbpharma.co.kr

HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co (XKRX:047920) Headlines

No Headlines